2023 Q1 Form 10-K Financial Statement

#000149315223010032 Filed on March 31, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $1.009M $978.7K $3.876M
YoY Change 0.88% -9.29% -16.81%
Cost Of Revenue $360.9K $339.1K $1.278M
YoY Change 27.49% 3.93% -0.52%
Gross Profit $648.1K $639.7K $2.598M
YoY Change -9.62% -15.02% -23.01%
Gross Profit Margin 64.23% 65.36% 67.02%
Selling, General & Admin $552.1K $849.9K $2.517M
YoY Change 7.51% 58.77% 18.81%
% of Gross Profit 85.19% 132.87% 96.89%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $34.92K $68.80K $133.1K
YoY Change 45.02% 88.6% -0.91%
% of Gross Profit 5.39% 10.76% 5.12%
Operating Expenses $552.1K $849.9K $2.517M
YoY Change 7.51% 58.77% 18.81%
Operating Profit $96.01K -$210.3K $80.84K
YoY Change -52.85% -196.72% -93.56%
Interest Expense $43.50K -$20.07K $194.6K
YoY Change -112.29% -101.81% -60.61%
% of Operating Profit 45.31% 240.78%
Other Income/Expense, Net -$101.6K -$375.4K
YoY Change -71.29% -70923.96%
Pretax Income -$5.570K -$230.3K -$294.5K
YoY Change -96.29% -117.33% -116.82%
Income Tax
% Of Pretax Income
Net Earnings -$5.565K -$230.3K -$294.5K
YoY Change -96.3% -117.33% -116.82%
Net Earnings / Revenue -0.55% -23.54% -7.6%
Basic Earnings Per Share $0.00 -$0.04
Diluted Earnings Per Share $0.00 -$0.03 -$0.04
COMMON SHARES
Basic Shares Outstanding 8.250M shares 8.225M shares 8.398M shares
Diluted Shares Outstanding 8.250M shares 8.398M shares

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $409.3K $280.1K $280.1K
YoY Change -30.83% -57.7% -57.7%
Cash & Equivalents $409.3K $280.1K $280.1K
Short-Term Investments
Other Short-Term Assets $31.55K $31.55K $31.55K
YoY Change 1.54% -8.23% -8.23%
Inventory
Prepaid Expenses
Receivables $336.6K $373.2K $373.2K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $777.5K $684.8K $684.8K
YoY Change -17.75% -33.16% -33.16%
LONG-TERM ASSETS
Property, Plant & Equipment $598.0K $665.6K $662.8K
YoY Change -21.47% -21.34% -18.62%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $34.70K $34.70K $34.70K
YoY Change 9.33% 9.33% 9.33%
Total Long-Term Assets $629.9K $697.5K $697.6K
YoY Change -20.59% -17.57% -17.57%
TOTAL ASSETS
Total Short-Term Assets $777.5K $684.8K $684.8K
Total Long-Term Assets $629.9K $697.5K $697.6K
Total Assets $1.407M $1.382M $1.382M
YoY Change -19.04% -26.11% -26.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $616.5K $555.5K $555.5K
YoY Change -23.6% -24.76% -24.76%
Accrued Expenses $77.85K $112.3K $112.3K
YoY Change -43.99% -10.39% -10.39%
Deferred Revenue
YoY Change
Short-Term Debt $583.2K $757.0K $757.0K
YoY Change -39.65% -32.18% -32.18%
Long-Term Debt Due $177.3K $31.72K $31.72K
YoY Change 530.67% 8.26% 8.26%
Total Short-Term Liabilities $1.940M $1.908M $1.908M
YoY Change -29.51% -29.92% -29.92%
LONG-TERM LIABILITIES
Long-Term Debt $976.8K $1.038M $1.038M
YoY Change -16.67% -21.96% -21.96%
Other Long-Term Liabilities $328.1K $328.1K $328.1K
YoY Change -17.37% -25.49% -25.49%
Total Long-Term Liabilities $1.305M $1.366M $1.366M
YoY Change -16.84% -22.84% -22.84%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.940M $1.908M $1.908M
Total Long-Term Liabilities $1.305M $1.366M $1.366M
Total Liabilities $3.245M $3.274M $3.274M
YoY Change -24.91% -27.13% -27.13%
SHAREHOLDERS EQUITY
Retained Earnings -$11.97M -$11.97M
YoY Change 2.52%
Common Stock $8.251K $8.251K
YoY Change -2.77%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.837M -$1.891M -$1.891M
YoY Change
Total Liabilities & Shareholders Equity $1.407M $1.382M $1.382M
YoY Change -19.04% -26.11% -26.11%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$5.565K -$230.3K -$294.5K
YoY Change -96.3% -117.33% -116.82%
Depreciation, Depletion And Amortization $34.92K $68.80K $133.1K
YoY Change 45.02% 88.6% -0.91%
Cash From Operating Activities $218.9K $11.00K $369.5K
YoY Change -8.41% -95.77% -59.1%
INVESTING ACTIVITIES
Capital Expenditures $14.85K $33.73K
YoY Change -151.1%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$14.85K -$33.73K
YoY Change -48.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$89.58K -90.36K -$717.9K
YoY Change -71.04% 75.32% 70.94%
NET CHANGE
Cash From Operating Activities $218.9K 11.00K $369.5K
Cash From Investing Activities -14.85K -$33.73K
Cash From Financing Activities -$89.58K -90.36K -$717.9K
Net Change In Cash $129.3K -94.21K -$382.1K
YoY Change -283.65% -145.14% -191.54%
FREE CASH FLOW
Cash From Operating Activities $218.9K $11.00K $369.5K
Capital Expenditures $14.85K $33.73K
Free Cash Flow $218.9K -$3.850K $335.7K
YoY Change -101.48% -65.36%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001416697
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 BLPG Gain Loss On Settlement Of Accounts Payable
GainLossOnSettlementOfAccountsPayable
usd
CY2022 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
usd
CY2021 BLPG Common Stock Issued For Services
CommonStockIssuedForServices
usd
CY2021 BLPG Stock Option Expense
StockOptionExpense
usd
CY2022 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022 us-gaap Stock Issued1
StockIssued1
usd
CY2021 BLPG Cancellation Of Common Stock
CancellationOfCommonStock
usd
CY2022Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
usd
CY2021Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
usd
CY2022 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
shares
CY2021 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
shares
CY2022 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
shares
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
usd
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
usd
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
usd
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
000-52942
CY2022 dei Entity Registrant Name
EntityRegistrantName
BLUE LINE PROTECTION GROUP, INC.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-5543728
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
5765 Logan Street
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Denver
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80216
CY2022 dei City Area Code
CityAreaCode
(800)
CY2022 dei Local Phone Number
LocalPhoneNumber
844-5576
CY2022 dei Security12g Title
Security12gTitle
Common Stock, $0.001 par value
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
1018000 usd
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
8250144 shares
CY2022 dei Auditor Firm
AuditorFirmId
2738
CY2022 dei Auditor Name
AuditorName
M&K CPAS, PLLC
CY2022 dei Auditor Location
AuditorLocation
Houston, TX
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
280073 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
662177 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
373175 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
328042 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
31553 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
34378 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
684801 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
1024597 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
408616 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
529711 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
704433 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
586130 usd
CY2022Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
254227 usd
CY2021Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
284776 usd
CY2022Q4 us-gaap Disposal Group Including Discontinued Operation Property Plant And Equipment
DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment
2782 usd
CY2021Q4 us-gaap Disposal Group Including Discontinued Operation Property Plant And Equipment
DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment
2782 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
665625 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
817269 usd
CY2022Q4 us-gaap Security Deposit
SecurityDeposit
31920 usd
CY2021Q4 us-gaap Security Deposit
SecurityDeposit
28958 usd
CY2022Q4 us-gaap Assets
Assets
1382346 usd
CY2021Q4 us-gaap Assets
Assets
1870824 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
555445 usd
CY2021Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
738221 usd
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
31719 usd
CY2021Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
29301 usd
CY2022Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
152771 usd
CY2021Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
541272 usd
CY2022Q4 BLPG Convertible Notes Payable Related Parties Current Net Of Unamortized Discount
ConvertibleNotesPayableRelatedPartiesCurrentNetOfUnamortizedDiscount
604256 usd
CY2021Q4 BLPG Convertible Notes Payable Related Parties Current Net Of Unamortized Discount
ConvertibleNotesPayableRelatedPartiesCurrentNetOfUnamortizedDiscount
575000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
112250 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
125266 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
451119 usd
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
712784 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1907560 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2721844 usd
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
37568 usd
CY2021Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
16402 usd
CY2022Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
1000500 usd
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1770585 usd
CY2022Q4 us-gaap Liabilities
Liabilities
3273744 usd
CY2021Q4 us-gaap Liabilities
Liabilities
4492429 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1366184 usd
CY2021Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
1313817 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
328116 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
440366 usd
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
20000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
20000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
20000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
20000000 shares
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
20000 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
20000 usd
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
14000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8250144 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8457364 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8398062 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8250144 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8485144 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8485144 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
8251 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
8486 usd
CY2022Q4 us-gaap Common Stock Shares Subscribed But Unissued
CommonStockSharesSubscribedButUnissued
129 shares
CY2021Q4 us-gaap Common Stock Shares Subscribed But Unissued
CommonStockSharesSubscribedButUnissued
129 shares
CY2022Q4 BLPG Common Stock Owed But Not Issued
CommonStockOwedButNotIssued
13 usd
CY2021Q4 BLPG Common Stock Owed But Not Issued
CommonStockOwedButNotIssued
13 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
10046096 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
9021126 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-11965758 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-11671230 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1891398 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-2621605 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1382346 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1870824 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3876227 usd
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4659393 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
1278239 usd
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
1284876 usd
CY2022 us-gaap Gross Profit
GrossProfit
2597988 usd
CY2021 us-gaap Gross Profit
GrossProfit
3374517 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2517149 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2118601 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
2517149 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
2118601 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
80839 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
1255916 usd
CY2021 BLPG Gain Loss On Settlement Of Accounts Payable
GainLossOnSettlementOfAccountsPayable
533 usd
CY2022 us-gaap Interest Expense
InterestExpense
194643 usd
CY2021 us-gaap Interest Expense
InterestExpense
583149 usd
CY2022 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-180724 usd
CY2021 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
1077289 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-375367 usd
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
494673 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-294528 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
1750589 usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.21
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8398062 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8457364 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8398062 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12314864 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8398062 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12314864 shares
CY2022 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
45288 usd
CY2021 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
78837 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-717850 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-419945 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-382104 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-5362111 usd
CY2021 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
10010 usd
CY2021 BLPG Rounding From Reverse Stock Split
RoundingFromReverseStockSplit
2 usd
CY2021 BLPG Adjustments To Additional Paid In Capital Derivative Resolution
AdjustmentsToAdditionalPaidInCapitalDerivativeResolution
457572 usd
CY2021 BLPG Additional Paid In Capital Gain On Forgiveness Of Accrued Interest Related Party
AdditionalPaidInCapitalGainOnForgivenessOfAccruedInterestRelatedParty
522333 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
1750589 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-2621605 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-2621605 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-2621605 usd
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
4750 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
327596 usd
CY2022 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
250000 usd
CY2022 BLPG Adjustments To Additional Paid In Capital Derivative Resolution
AdjustmentsToAdditionalPaidInCapitalDerivativeResolution
442389 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-294528 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1891398 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1891398 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-294528 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
1750589 usd
CY2022 us-gaap Depreciation
Depreciation
133146 usd
CY2021 us-gaap Depreciation
Depreciation
134371 usd
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
121095 usd
CY2021 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
107257 usd
CY2022 BLPG Common Stock Issued For Services
CommonStockIssuedForServices
4750 usd
CY2022 BLPG Stock Option Expense
StockOptionExpense
327596 usd
CY2022 us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
180724 usd
CY2021 us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
-1077289 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
45133 usd
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5444 usd
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
137 usd
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1038 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
67224 usd
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
100094 usd
CY2022 BLPG Increase Decrease In Lease Obligation
IncreaseDecreaseInLeaseObligation
125266 usd
CY2021 BLPG Increase Decrease In Lease Obligation
IncreaseDecreaseInLeaseObligation
107242 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
369471 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
903374 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
33725 usd
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
66002 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-33725 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-66002 usd
CY2021 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
175097 usd
CY2022 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
313318 usd
CY2021 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
146011 usd
CY2022 BLPG Repayments From Notes Payable Related Party
RepaymentsFromNotesPayableRelatedParty
359244 usd
CY2021 BLPG Repayments From Notes Payable Related Party
RepaymentsFromNotesPayableRelatedParty
20000 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
417427 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
662177 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
244750 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
280073 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
662177 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
56204 usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
400256 usd
CY2022 BLPG Capitalized Leased Fixed Assets
CapitalizedLeasedFixedAssets
68872 usd
CY2021 BLPG Capitalized Leased Fixed Assets
CapitalizedLeasedFixedAssets
56735 usd
CY2021 us-gaap Stock Issued1
StockIssued1
10010 usd
CY2022 BLPG Derivative Resolution
DerivativeResolution
442389 usd
CY2021 BLPG Derivative Resolution
DerivativeResolution
457572 usd
CY2022 BLPG Cancellation Of Common Stock
CancellationOfCommonStock
260 usd
CY2022 BLPG Gain On Forgiveness Of Accrued Interest Related Party
GainOnForgivenessOfAccruedInterestRelatedParty
250000 usd
CY2021 BLPG Gain On Forgiveness Of Accrued Interest Related Party
GainOnForgivenessOfAccruedInterestRelatedParty
522334 usd
CY2006Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2006Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q2 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
On May 6, 2014, the Company effected a forward stock split and a pro-rata increase in its authorized common stock on a basis of 14-to-1, whereby each shareholder received 14 newly issued shares of common stock for each 1 share held
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1400000000 shares
CY2021Q3 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
On July 6, 2021, the Company effected a reverse stock split and a pro-rata decrease in its authorized common stock on a basis of 1-for-100, the authorized capital of the Company concurrently decreased to 14,000,000 shares of common stock.
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
14000000 shares
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_842_eus-gaap--ConcentrationRiskCreditRisk_z17sgZw9xAtf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Concentration of business and credit risk</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has no significant off-balance sheet risks such as foreign exchange contracts, option contracts or other hedging arrangements. The Company’s financial instruments that are exposed to concentration of credit risks consist primarily of cash. The Company maintains its cash in bank accounts, which may at times, exceed federally insured limits.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company had one major customer which generated <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--OneMajorCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zHGyu37wPOX1" title="Concentration credit risk, percentage">16</span>% of total revenue in the year ended December 31, 2022 and one customer comprised <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--OneMajorCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zPsEAyyvtjFh" title="Concentration credit risk, percentage">22</span>% of the account receivable balance at December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company had one major customer which generated <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__srt--MajorCustomersAxis__custom--OneMajorCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zJfgwoYyG999" title="Concentration credit risk, percentage">22</span>% of total revenue in the year ended December 31, 2021 and one customer comprised <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__srt--MajorCustomersAxis__custom--OneMajorCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zOEhOpFcLq5j" title="Concentration credit risk, percentage">35</span>% of the account receivable balance at December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84F_eus-gaap--UseOfEstimates_zogEqw98Dowb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Use of estimates</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
30073 usd
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2022 us-gaap Financing Receivable Allowance For Credit Losses Policy For Uncollectible Amounts
FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts
<p id="xdx_840_eus-gaap--FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts_znUQH1oEENG3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Allowance for uncollectible accounts</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company estimates losses on receivables based on known troubled accounts, if any, and historical experience of losses incurred. There was <span id="xdx_903_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_do_c20221231_zOUuQKUpbv79" title="Allowance for doubtful receivables"><span id="xdx_908_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_do_c20211231_zUqQBwXCFfrf" title="Allowance for doubtful receivables">no</span></span> allowance for doubtful customer receivables at December 31, 2022 and December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2021 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2022 us-gaap Depreciation
Depreciation
133146 usd
CY2021 us-gaap Depreciation
Depreciation
134371 usd
CY2022Q4 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
451119 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
451119 usd
CY2021Q4 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
712784 usd
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
712784 usd
CY2022 us-gaap Revenues
Revenues
3876227 usd
CY2021 us-gaap Revenues
Revenues
4659393 usd
CY2022 us-gaap Advertising Expense
AdvertisingExpense
9808 usd
CY2021 us-gaap Advertising Expense
AdvertisingExpense
4298 usd
CY2022Q4 BLPG Operating Right Of Use Assets Lease
OperatingRightOfUseAssetsLease
408616 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
408616 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
112250 usd
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3022000 shares
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-294528 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
1750589 usd
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8398062 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8457364 shares
CY2021 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
3875500 shares
CY2022 BLPG Diluted Weightedaverage Of Common Stock
DilutedWeightedaverageOfCommonStock
8398062 shares
CY2021 BLPG Diluted Weightedaverage Of Common Stock
DilutedWeightedaverageOfCommonStock
12314864 shares
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.21
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
328116 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
440366 usd
CY2022Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
34346 usd
CY2021Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
34346 usd
CY2022Q4 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
31719 usd
CY2022Q4 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
37568 usd
CY2022Q4 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
69287 usd
CY2019Q1 us-gaap Debt Instrument Interest Rate Increase Decrease
DebtInstrumentInterestRateIncreaseDecrease
0.12 pure
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y6M
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.12 pure
CY2022 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
121095 usd
CY2022 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
6673 usd
CY2022 BLPG Finance Lease Expense
FinanceLeaseExpense
127768 usd
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
125266 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
158298 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
138532 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
141302 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
107558 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
545690 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
105324 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
440366 usd
CY2021Q4 BLPG Operating Right Of Use Assets Lease
OperatingRightOfUseAssetsLease
529711 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
529711 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
125266 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
440366 usd
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
565632 usd
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y6M
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.12 pure
CY2021 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
107257 usd
CY2021 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
77121 usd
CY2021 BLPG Finance Lease Expense
FinanceLeaseExpense
184378 usd
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
107242 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
958660 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
870906 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
704433 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
586130 usd
CY2022Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
254227 usd
CY2021Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
284776 usd
CY2022Q4 us-gaap Disposal Group Including Discontinued Operation Property Plant And Equipment
DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment
2782 usd
CY2021Q4 us-gaap Disposal Group Including Discontinued Operation Property Plant And Equipment
DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment
2782 usd
CY2022 us-gaap Depreciation
Depreciation
133146 usd
CY2021 us-gaap Depreciation
Depreciation
134371 usd
CY2022Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
137500 usd
CY2022Q1 us-gaap Debt Instrument Periodic Payment Principal
DebtInstrumentPeriodicPaymentPrincipal
12500 usd
CY2022Q3 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
137500 usd
CY2022Q3 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.075 pure
CY2022Q3 BLPG Accrued Interest Debt Forgive
AccruedInterestDebtForgive
250000 usd
CY2022Q3 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.075 pure
CY2022Q3 BLPG Default Rate Percentage
DefaultRatePercentage
0.12 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
92500 shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0.21
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3022000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.21
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1541000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.21
CY2020Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
2247645 usd
CY2021 BLPG Settlement Of Derivatives Upon Conversion
SettlementOfDerivativesUponConversion
-457572 usd
CY2021 us-gaap Derivative Fair Value Hedge Included In Effectiveness Gain Loss
DerivativeFairValueHedgeIncludedInEffectivenessGainLoss
-1077289 usd
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
712784 usd
CY2022 BLPG Settlement Of Derivatives Upon Conversion
SettlementOfDerivativesUponConversion
-442389 usd
CY2022 us-gaap Derivative Fair Value Hedge Included In Effectiveness Gain Loss
DerivativeFairValueHedgeIncludedInEffectivenessGainLoss
180724 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
451119 usd
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2014Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1400000000 shares
CY2021Q3 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
On July 6, 2021, the Company effected a reverse stock split and a pro-rata decrease in its authorized common stock on a basis of 1-for-100, the authorized capital of the Company concurrently decreased to 14,000,000 shares of common stock.
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
14000000 shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3114500 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.21
CY2022 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
0.21
CY2020 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
0.21
CY2022Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
3022000 shares
CY2020Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
3022000 shares
CY2022 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P4Y9M
CY2020 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P4Y9M
CY2022Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
0.21
CY2020Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
0.21
CY2022Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
1541000 shares
CY2020Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
1541000 shares
CY2022Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
0.21
CY2020Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
0.21
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
327596 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Deductions
EffectiveIncomeTaxRateReconciliationDeductions
0.80 pure
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1874970 usd
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1843905 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1874970 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1843905 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1874970 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1843905 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
31065 usd
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
202258 usd
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
8928427 usd
CY2021Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
8780500 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1874970 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1843905 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.210 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.210 pure

Files In Submission

Name View Source Status
blpg-20221231_cal.xml Edgar Link unprocessable
blpg-20221231_lab.xml Edgar Link unprocessable
0001493152-23-010032-index-headers.html Edgar Link pending
0001493152-23-010032-index.html Edgar Link pending
0001493152-23-010032.txt Edgar Link pending
0001493152-23-010032-xbrl.zip Edgar Link pending
blpg-20221231.xsd Edgar Link pending
ex31.htm Edgar Link pending
ex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
image_001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
blpg-20221231_def.xml Edgar Link unprocessable
blpg-20221231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
form10-k_htm.xml Edgar Link completed
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending